Table 3

Reasons for not being on a long-term oral anticoagulant strategy after discharge (n=95)

Patient refusal2/95 (2.1)
Bleeding risk82/95 (86.3)
 Previous haemorrhage54/82 (65.8)
 Intracranial42/54 (77.8)
 GI bleed5/54 (9.3)
 ENT1/54 (1.9)
 Respiratory tract2/54 (3.7)
 Superficial/haematoma3/54 (5.6)
 Genitourinary tract4/54 (7.4)
 Chronic anaemia2/54 (3.7)
 Trauma4/54 (7.4)
 Other2/54 (3.7)
 Never bleed but perceived as at increased risk of bleeding28/82 (34.1)
Unobservant or perceived as unobservant1/95 (1.1)
Uncertainty about patient’s ability to understand treatment*6/95 (6.3)
Others17/95 (17.8)
 Chronic alcoholism or drug addiction0/17 (0.0)
 Severe hepatic disease0/17 (0.0)
 Specific contraindication to VKA0/17 (0.0)
 Specific contraindication to NOAC1/17 (5.8)
 Bedridden and cognitive deterioration16/17 (94.1)
  • *Cognitive deterioration, low level of education, not French speaking.

  • ENT, ear, nose, throat; NOAC, new oral anticoagulant; VKA, vitamin K antagonist.